期刊文献+

In vitro anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia officinalis leaves 被引量:2

In vitro anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia officinalis leaves
原文传递
导出
摘要 AIM: The anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia officinalis leaves against extracellular(promastigote) and intracellular(amastigote) forms of Leishmania major were evaluated in this study. METHOD: In the first stage, promastigote forms of L. major, were treated with different doses of the plant extracts in a 96-well tissue-culture microplate and IC50 values for each extract were measured with colorimetric MTT assay. In the second stage, macrophage cells were infected with L. major promastigotes. Infected macrophages were treated with plant extracts. Then the macrophages were stained with Gimsa and the number of infected macrophages and amastigotes were counted with a light microscope. RESULTS: The results indicated that the plant extracts inhibited the growth of promastigotes and amastigotes of L. major. Inhibitory concentrations(IC50) for promastigote assay were 108.19, 155.15, and 184.32 μg·mL-1 for C. officinalis flowers, D. stramonium seeds and S. officinalis, respectively. The extracts also reduced the number of amastigotes in macrophage cells from 264 for control group to 88, 97, and 102 for test groups. Although the anti-leishmanial activity of the extracts were not comparable with the standard drug, miltefosine; but they showed significant efficiency in reducing the number of amastigotes in macrophages, in comparison with the control group(P < 0.001). These plant extracts had lower toxicity compared with miltefosine. CONCLUSION: This study demonstrates the potential efficacy of the methanolic extracts of C. officinalis flowers, D. stramonium seeds, and S. officinalis leaves to control of cutaneous leishmaniasis. AIM: The anti-leishmanial activity of methanolic extracts of Calendula officinalis flowers, Datura stramonium seeds, and Salvia officina- lis leaves against extracellular (promastigote) and intracellular (amastigote) forms of Leishmania major were evaluated in this study. METHOD: In the first stage, promastigote forms of L. major, were treated with different doses of the plant extracts in a 96-well tis- sue-culture microplate and IC50 values for each extract were measured with colorimetric MTT assay. In the second stage, macrophage cells were infected with L. major promastigotes. Infected macrophages were treated with plant extracts. Then the macrophages were stained with Gimsa and the number of infected macrophages and amastigotes were counted with a light microscope. RESULTS: The results indicated that the plant extracts inhibited the growth of promastigotes and amastigotes of L. major. Inhibi- tory concentrations (ICs0) for promastigote assay were 108.19, 155.15, and 184.32 μg-mL ^-1 for C. officinalis flowers, D. stramo- nium seeds and S. officinalis, respectively. The extracts also reduced the number of amastigotes in macrophage cells from 264 for control group to 88, 97, and 102 for test groups. Although the anti-leishmanial activity of the extracts were not comparable with the standard drug, miltefosine; but they showed significant efficiency in reducing the number of amastigotes in macrophages, in com- parison with the control group (P 〈 0.001). These plant extracts had lower toxicity compared with miltefosine. CONCLUSION: This study demonstrates the potential efficacy of the methanolic extracts of C. officinalis flowers, D. stramonium seeds, and S. officinalis leaves to control of cutaneous leishmaniasis.
出处 《Chinese Journal of Natural Medicines》 SCIE CAS CSCD 2014年第6期423-427,共5页 中国天然药物(英文版)
关键词 Leishmania major PROMASTIGOTE Amastigote Calendula officinalis Datura stramonium Salvia officinalis Leishmania major Promastigote Amastigote Calendula officinalis Datura stramonium Salvia officinalis
  • 相关文献

参考文献31

  • 1Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishma-niasis [J]. Lancet Infect Dis, 2007, 7 (9): 581-596.
  • 2Murray HW, Berman JD, Davies CR, et al. Advances in leish-maniasis [J]. Lancet, 2005,4 (366): 1561-1577.
  • 3www.who.int/leishmaniasis/burden/en/.
  • 4Lee SA, Hasbun R. Therapy of cutaneous leishmaniasis [J]. IntJ Infect Dis, 2003, 7: 86-93.
  • 5Andersen EM, Cruz-Saldarriaga M, Lanos-Cuentas A, et al.Camparison of meglumine antimoniate and pentamidine forPeruvian cutaneous leishmaniasis [J]. Am J Trop Med Hyg,2005,72 (2): 133-137.
  • 6Griewank K, Gazeau C, Eichhom A, et al. Miltefosine effi-ciently eliminates Leishmania major amastigotes from infectedmurine dendritic cells without altering their immune functions[J]. Antimicrob Agents Chemother, 2010, 54 (2): 652-659.
  • 7Santos D, Coutinho C, Madeira M, et al. Leishmaniasis treat-ment-a challenge that remains: a review [J]. Parasitol Res, 2008,103: 1-10.
  • 8Kumar Haidar A, Sen P, Roy S. Use of antimony in the treat-ment of leishmaniasis: current status and future directions [J].Mol Biol Int, 2011: 1-23.
  • 9Alviano DS, Alviano CS. Plant extracts: Search for new alter-natives to treat microbial diseases [J]. Curr Pharm Biotechnol,2009,10: 106-121.
  • 10Kayser O, Kiderlen AF, Croft SL. Natural products as antipara-sitic drugs [J]. Parasitol Res, 2003, 90: 55-62.

同被引文献6

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部